Kenneth S Koblan Selected Research

Trace amine-associated receptor 1

1/2022	Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.
1/2022	Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats.
12/2021	Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study.
10/2021	Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia.
1/2021	Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans.
1/2020	A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth S Koblan Research Topics

Disease

13	Schizophrenia (Dementia Praecox) 05/2022 - 11/2010
7	Migraine Disorders (Migraine) 11/2009 - 01/2002
6	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 07/2009
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 11/2015
3	Body Weight (Weight, Body) 12/2021 - 06/2009
3	Parkinson Disease (Parkinson's Disease) 07/2011 - 10/2008
3	Pain (Aches) 11/2010 - 02/2003
3	Hyperalgesia 07/2007 - 02/2003
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 01/2019
2	Major Depressive Disorder (Major Depressive Disorders) 10/2016 - 08/2013
2	Neuralgia (Stump Neuralgia) 07/2011 - 08/2002
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Mood Disorders (Mood Disorder) 01/2021
1	Bulimia (Binge Eating) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2020
1	Headache (Headaches) 01/2020
1	Sleepiness 01/2020
1	Neurobehavioral Manifestations 10/2019
1	Nervous System Diseases (Neurological Disorders) 11/2010
1	Epilepsy (Aura) 11/2010
1	Hyperemia 11/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2009
1	Myocardial Infarction 11/2009
1	Weight Gain 06/2009
1	Obesity 06/2009
1	Long QT Syndrome 05/2009
1	Atrial Fibrillation 01/2009
1	Cardiac Arrhythmias (Arrythmia) 01/2009
1	Essential Tremor (Essential Tremors) 10/2008
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2008
1	Seizures (Absence Seizure) 10/2008
1	Alzheimer Disease (Alzheimer's Disease) 11/2006
1	Heart Failure 11/2003

Drug/Important Bio-Agent (IBA)

9	SEP-363856IBA 05/2022 - 10/2019
6	Trace amine-associated receptor 1IBA 01/2022 - 01/2020
6	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2021 - 11/2015
6	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 02/2008 - 01/2002
5	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 11/2009
5	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2018
5	Calcitonin Gene-Related PeptideIBA 02/2008 - 01/2002
3	5-HT1A Serotonin ReceptorIBA 05/2022 - 10/2016
3	Serotonin 5-HT1 Receptor AgonistsIBA 05/2022 - 10/2021
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
3	CarrageenanIBA 07/2007 - 02/2003
2	Amisulpride (Solian)IBA 01/2022 - 01/2021
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2020 - 10/2019
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 11/2010 - 06/2009
2	piperidineIBA 02/2008 - 11/2007
2	olcegepantIBA 02/2008 - 01/2002
1	ProlactinIBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	CholesterolIBA 12/2021
1	TabletsIBA 10/2021
1	Capsules (Microcapsules)IBA 10/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Phencyclidine (Angel Dust)IBA 10/2019
1	Chlorpromazine (Thorazine)FDA Link 10/2019
1	Lurasidone Hydrochloride FDA Link 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 02/2016
1	3,4-dihydroxyphenylglycolIBA 02/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2016
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 08/2013
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 08/2013
1	Orexin Receptor AntagonistsIBA 01/2010
1	Tryptamines (Triptans)IBA 11/2009
1	Sumatriptan (Imigran)FDA LinkGeneric 11/2009
1	OrexinsIBA 07/2009
1	2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA 06/2009
1	triphenylphosphine oxideIBA 01/2009
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2009
1	compound 30IBA 10/2008
1	NeuropeptidesIBA 02/2008
1	telcagepantIBA 02/2008
1	Peptides (Polypeptides)IBA 11/2006
1	Amyloid beta-PeptidesIBA 11/2006
1	Amyloid (Amyloid Fibrils)IBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	BenzodiazepinesIBA 10/2006
1	PiperidinesIBA 10/2006
1	benzimidazoleIBA 04/2004

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2008
2	Ligation 07/2011 - 08/2002
1	Oral Administration 07/2011